Inspire Investing, LLC Bluebird Bio, Inc. Transaction History

Inspire Investing, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$2.94 - $5.23 $5,212 - $9,272	1,773 Added 3.64%	50,497 $209,000
Q1 2022 Apr 21, 2022	BUY	$4.07 - $10.6 $98,025 - $255,301	24,085 Added 97.75%	48,724 $236,000
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $220,765 - $401,862	24,639 New	24,639 $246,000
Q4 2021 Feb 03, 2022	SELL	$8.96 - $16.31 $113,550 - $206,696	-12,673 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$11.24 - $21.0 $142,444 - $266,133	12,673 New	12,673 $242,000
Q2 2020 Aug 12, 2020	SELL	$27.12 - $45.97 $135 - $229	-5 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$26.16 - $63.5 $130 - $317	5 New	5 $0
Q1 2018 Apr 13, 2018	SELL	$105.8 - $150.94 $33,961 - $48,451	-321 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$81.25 - $130.7 $26,081 - $41,954	321	321 $57,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.